These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 11596909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic monitoring of HIV-1 protease inhibitors in the antiretroviral therapy.
    Pawiński T, Pulik P, Gralak B, Horban A.
    Acta Pol Pharm; 2008; 65(1):93-100. PubMed ID: 18536180
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography.
    Yamada H, Kotaki H, Nakamura T, Iwamoto A.
    J Chromatogr B Biomed Sci Appl; 2001 May 05; 755(1-2):85-9. PubMed ID: 11393736
    [Abstract] [Full Text] [Related]

  • 7. Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
    Poirier JM, Robidou P, Jaillon P.
    Ther Drug Monit; 2005 Apr 05; 27(2):186-92. PubMed ID: 15795650
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
    Marzolini C, Telenti A, Buclin T, Biollaz J, Decosterd LA.
    J Chromatogr B Biomed Sci Appl; 2000 Mar 31; 740(1):43-58. PubMed ID: 10798293
    [Abstract] [Full Text] [Related]

  • 9. High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
    Titier K, Lagrange F, Péhourcq F, Edno-Mcheik L, Moore N, Molimard M.
    Ther Drug Monit; 2002 Jun 31; 24(3):417-24. PubMed ID: 12021635
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
    Sarasa-Nacenta M, López-Púa Y, Mallolas J, Blanco JL, Gatell JM, Carné X.
    J Chromatogr B Biomed Sci Appl; 2001 Jun 15; 757(2):325-32. PubMed ID: 11417878
    [Abstract] [Full Text] [Related]

  • 12. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction.
    Dailly E, Thomas L, Kergueris MF, Jolliet P, Bourin M.
    J Chromatogr B Biomed Sci Appl; 2001 Jul 15; 758(2):129-35. PubMed ID: 11486821
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Dickinson L, Robinson L, Tjia J, Khoo S, Back D.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec 27; 829(1-2):82-90. PubMed ID: 16226495
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic interactions between HIV-1 protease inhibitors in rats: study on combinations of two kinds of HIV-1 protease inhibitors.
    Shibata N, Matsumura Y, Okamoto H, Kawaguchi Y, Ohtani A, Yoshikawa Y, Takada K.
    J Pharm Pharmacol; 2000 Oct 27; 52(10):1239-46. PubMed ID: 11092568
    [Abstract] [Full Text] [Related]

  • 16. High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
    Choi SO, Rezk NL, Kashuba AD.
    J Pharm Biomed Anal; 2007 Mar 12; 43(4):1562-7. PubMed ID: 17236737
    [Abstract] [Full Text] [Related]

  • 17. Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.
    Colombo S, Guignard N, Marzolini C, Telenti A, Biollaz J, Decosterd LA.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct 15; 810(1):25-34. PubMed ID: 15358304
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Application of a rapid and selective method for the simultaneous determination of protease inhibitors, lopinavir and ritonavir in human plasma by UPLC-ESI-MS/MS for bioequivalence study in Indian subjects.
    Yadav M, Rao R, Kurani H, Singhal P, Goswami S, Shrivastav PS.
    J Pharm Biomed Anal; 2009 May 01; 49(4):1115-22. PubMed ID: 19282124
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.